Black Diamond Therapeutics Inc (NASDAQ: BDTX): The Best-Of-Breed For Investing?
Currently, there are 51.65M common shares owned by the public and among those 43.07M shares have been available to trade. The company’s stock has a 5-day price change of -16.97% and -7.79% over the past three months. BDTX shares are trading 60.14% year to date (YTD), with the 12-month market performance up to 32.35% higher. […]
Black Diamond Therapeutics Inc (NASDAQ: BDTX): Hunting Genuine Value In Market Debris
Bellevue Asset Management AG recently announced the acquisition of new stake in Black Diamond Therapeutics Inc (NASDAQ:BDTX). The institutional investor has increased its shareholding in the Healthcare company by 4.70% to 8.52 million shares with purchase of 0.38 million shares. This fresh investment now brings its stake to 16.50% valued currently at $23.94 million. In […]
Value Hunters: Look To Black Diamond Therapeutics Inc (BDTX)
Bellevue Asset Management AG recently announced the acquisition of new stake in Black Diamond Therapeutics Inc (NASDAQ:BDTX). The institutional investor has increased its shareholding in the Healthcare company by 4.70% to 8.52 million shares with purchase of 0.38 million shares. This fresh investment now brings its stake to 16.50% valued currently at $19.93 million. In […]
